Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Pegylated Human Granulocyte Colony-stimulating Factor Injection

Approval Number

国药准字S20250005

Company杭州九源基因工程股份有限公司

Registration Date

January 14, 2025

Drug Information

Generic Name

聚乙二醇化重组人粒细胞刺激因子注射液

Dosage Form

注射剂

Strength

预充式注射器装：6mg（0.6ml）/支

Drug Type

生物制品

Registration Date

January 14, 2025

Company Information

Applicant Company

Company Name杭州九源基因工程股份有限公司

Company Address

浙江省杭州市钱塘区白杨街道8号大街23号

Manufacturing Company

Company Name杭州九源基因工程股份有限公司

Company Address

杭州经济技术开发区八号大街东

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

聚乙二醇化重组人粒细胞刺激因子注射液 - NMPA 批准文号 | MedPath